Cargando…
A randomized controlled trial to prevent glycemic relapse in longitudinal diabetes care: Study protocol (NCT00362193)
BACKGROUND: Diabetes is a common disease with self-management a key aspect of care. Large prospective trials have shown that maintaining glycated hemoglobin less than 7% greatly reduces complications but translating this level of control into everyday clinical practice can be difficult. Intensive im...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1634866/ https://www.ncbi.nlm.nih.gov/pubmed/17054790 http://dx.doi.org/10.1186/1748-5908-1-24 |
_version_ | 1782130650906624000 |
---|---|
author | Huizinga, Mary Margaret Shintani, Ayumi Michon, Stephanie Brown, Anne Wolff, Kathleen Shackleford, Laurie King, Elaine Boswell Gregory, Rebecca Pratt Davis, Dianne Stiles, Renee Gebretsadik, Tebeb Chen, Kong Rothman, Russell Pichert, James W Schlundt, David Elasy, Tom A |
author_facet | Huizinga, Mary Margaret Shintani, Ayumi Michon, Stephanie Brown, Anne Wolff, Kathleen Shackleford, Laurie King, Elaine Boswell Gregory, Rebecca Pratt Davis, Dianne Stiles, Renee Gebretsadik, Tebeb Chen, Kong Rothman, Russell Pichert, James W Schlundt, David Elasy, Tom A |
author_sort | Huizinga, Mary Margaret |
collection | PubMed |
description | BACKGROUND: Diabetes is a common disease with self-management a key aspect of care. Large prospective trials have shown that maintaining glycated hemoglobin less than 7% greatly reduces complications but translating this level of control into everyday clinical practice can be difficult. Intensive improvement programs are successful in attaining control in patients with type 2 diabetes, however, many patients experience glycemic relapse once returned to routine care. This early relapse is, in part, due to decreased adherence in self-management behaviors. OBJECTIVE: This paper describes the design of the Glycemic Relapse Prevention study. The purpose of this study is to determine the optimal frequency of maintenance intervention needed to prevent glycemic relapse. The primary endpoint is glycemic relapse, which is defined as glycated hemoglobin greater than 8% and an increase of 1% from baseline. METHODS: The intervention consists of telephonic contact by a nurse practitioner with a referral to a dietitian if indicated. This intervention was designed to provide early identification of self-care problems, understanding the rationale behind the self-care lapse and problem solve to find a negotiated solution. A total of 164 patients were randomized to routine care (least intensive), routine care with phone contact every three months (moderate intensity) or routine care with phone contact every month (most intensive). CONCLUSION: The baseline patient characteristics are similar across the treatment arms. Intervention fidelity analysis showed excellent reproducibility. This study will provide insight into the important but poorly understood area of glycemic relapse prevention. |
format | Text |
id | pubmed-1634866 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-16348662006-11-07 A randomized controlled trial to prevent glycemic relapse in longitudinal diabetes care: Study protocol (NCT00362193) Huizinga, Mary Margaret Shintani, Ayumi Michon, Stephanie Brown, Anne Wolff, Kathleen Shackleford, Laurie King, Elaine Boswell Gregory, Rebecca Pratt Davis, Dianne Stiles, Renee Gebretsadik, Tebeb Chen, Kong Rothman, Russell Pichert, James W Schlundt, David Elasy, Tom A Implement Sci Study Protocol BACKGROUND: Diabetes is a common disease with self-management a key aspect of care. Large prospective trials have shown that maintaining glycated hemoglobin less than 7% greatly reduces complications but translating this level of control into everyday clinical practice can be difficult. Intensive improvement programs are successful in attaining control in patients with type 2 diabetes, however, many patients experience glycemic relapse once returned to routine care. This early relapse is, in part, due to decreased adherence in self-management behaviors. OBJECTIVE: This paper describes the design of the Glycemic Relapse Prevention study. The purpose of this study is to determine the optimal frequency of maintenance intervention needed to prevent glycemic relapse. The primary endpoint is glycemic relapse, which is defined as glycated hemoglobin greater than 8% and an increase of 1% from baseline. METHODS: The intervention consists of telephonic contact by a nurse practitioner with a referral to a dietitian if indicated. This intervention was designed to provide early identification of self-care problems, understanding the rationale behind the self-care lapse and problem solve to find a negotiated solution. A total of 164 patients were randomized to routine care (least intensive), routine care with phone contact every three months (moderate intensity) or routine care with phone contact every month (most intensive). CONCLUSION: The baseline patient characteristics are similar across the treatment arms. Intervention fidelity analysis showed excellent reproducibility. This study will provide insight into the important but poorly understood area of glycemic relapse prevention. BioMed Central 2006-10-20 /pmc/articles/PMC1634866/ /pubmed/17054790 http://dx.doi.org/10.1186/1748-5908-1-24 Text en Copyright © 2006 Huizinga et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Study Protocol Huizinga, Mary Margaret Shintani, Ayumi Michon, Stephanie Brown, Anne Wolff, Kathleen Shackleford, Laurie King, Elaine Boswell Gregory, Rebecca Pratt Davis, Dianne Stiles, Renee Gebretsadik, Tebeb Chen, Kong Rothman, Russell Pichert, James W Schlundt, David Elasy, Tom A A randomized controlled trial to prevent glycemic relapse in longitudinal diabetes care: Study protocol (NCT00362193) |
title | A randomized controlled trial to prevent glycemic relapse in longitudinal diabetes care: Study protocol (NCT00362193) |
title_full | A randomized controlled trial to prevent glycemic relapse in longitudinal diabetes care: Study protocol (NCT00362193) |
title_fullStr | A randomized controlled trial to prevent glycemic relapse in longitudinal diabetes care: Study protocol (NCT00362193) |
title_full_unstemmed | A randomized controlled trial to prevent glycemic relapse in longitudinal diabetes care: Study protocol (NCT00362193) |
title_short | A randomized controlled trial to prevent glycemic relapse in longitudinal diabetes care: Study protocol (NCT00362193) |
title_sort | randomized controlled trial to prevent glycemic relapse in longitudinal diabetes care: study protocol (nct00362193) |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1634866/ https://www.ncbi.nlm.nih.gov/pubmed/17054790 http://dx.doi.org/10.1186/1748-5908-1-24 |
work_keys_str_mv | AT huizingamarymargaret arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT shintaniayumi arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT michonstephanie arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT brownanne arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT wolffkathleen arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT shacklefordlaurie arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT kingelaineboswell arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT gregoryrebeccapratt arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT davisdianne arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT stilesrenee arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT gebretsadiktebeb arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT chenkong arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT rothmanrussell arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT pichertjamesw arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT schlundtdavid arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT elasytoma arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT huizingamarymargaret randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT shintaniayumi randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT michonstephanie randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT brownanne randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT wolffkathleen randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT shacklefordlaurie randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT kingelaineboswell randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT gregoryrebeccapratt randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT davisdianne randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT stilesrenee randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT gebretsadiktebeb randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT chenkong randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT rothmanrussell randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT pichertjamesw randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT schlundtdavid randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 AT elasytoma randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193 |